Jordan Wittig, is a medicare enrolled "Physician Assistant" in Aurora, Ohio. Her current practice location is
350 Blair Cir, Aurora, Ohio. You can reach out to her office (for appointments etc.) via phone at
(330) 998-5950.
Jordan Wittig is licensed to practice in Ohio (license number 50.008435RX) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1174210199.
Provider's Profile
| Full Name | Jordan Wittig |
|---|
| Gender | Female |
|---|
| Speciality | Physician Assistant |
|---|
| Location | 350 Blair Cir, Aurora, Ohio |
|---|
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
NPI Data:
- NPI Number: 1174210199
- Provider Enumeration Date: 04/19/2023
- Last Update Date: 05/30/2025
Medicare PECOS Information:
- PECOS PAC ID: 2264887413
- Enrollment ID: I20231009002601
Medical Identifiers
Medical identifiers for Jordan Wittig such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
| 1174210199 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
| 363A00000X | Physician Assistant | 50.008435RX (Ohio) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jordan Wittig is
enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
Jordan Wittig, 350 Blair Cir, Aurora, OH 44202-7663 Ph: (330) 998-5950 | Jordan Wittig, 350 Blair Cir, Aurora, OH 44202-7663 Ph: (330) 998-5950 |
Reviews and Comments